Table 5. CEC nucleolar characteristics by diagnostic grouping.

	n (%)
Malignant-Nucleoli not seen	66 (73.3%)
Malignant-nucleoli present	17 (18.9%)
Malignant-prominent nucleoli present	7 (7.8%)
Benign- Nucleoli not seen	19 (76.0%)
Benign-nucleoli present	5 (20.0%)
Benign-prominent nucleoli present	1 (4.0%)
p-value = 1.00
Neoplastic-Nucleoli not seen	77 (72.6%)
Neoplastic-nucleoli present	21 (19.8%)
Neoplastic-prominent nucleoli present	8 (7.5%)
Non-neoplastic-Nucleoli not seen	8 (88.9%)
Non-neoplastic-nucleoli present	1 (11.1%)
Non-neoplastic-prominent nucleoli present	0 (0%)
p-value = 0.84
PDAC-Nucleoli not seen	54 (75.0%)
PDAC-nucleoli present	13 (18.1%)
PDAC-prominent nucleoli present	5 (6.9%)
NET-Nucleoli not seen	5 (62.5%)
NET-nucleoli present	2 (25.0%)
NET-prominent nucleoli present	1 (12.5%)
p-value = 0.52

CEC: Circulating epithelioid cells. PDAC: Pancreatic ductal adenocarcinoma. NET: Neuroendocrine tumor.